These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16903132)

  • 21. Inter- and intraindividual variability in recognition memory: effects of aging and estrogen use.
    Wegesin DJ; Stern Y
    Neuropsychology; 2004 Oct; 18(4):646-57. PubMed ID: 15506832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease.
    Simpkins JW; Green PS; Gridley KE; Singh M; de Fiebre NC; Rajakumar G
    Am J Med; 1997 Sep; 103(3A):19S-25S. PubMed ID: 9344403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcohol and estrogen replacement therapy in postmenopausal women. Direct and mediated effects on cognitive component processes.
    Tivis LJ; Ceballos NA; Chastain G; Tivis RD
    Neuropsychobiology; 2008; 58(2):104-10. PubMed ID: 18843196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olfactory testing in consecutive patients referred with suspected dementia.
    Christensen IT; Larsson EM; Holm IE; Nielsen OBF; Andersen S
    BMC Geriatr; 2017 Jun; 17(1):129. PubMed ID: 28633628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of estrogens for the prevention and treatment of Alzheimer's disease.
    Monk D; Brodaty H
    Dement Geriatr Cogn Disord; 2000; 11(1):1-10. PubMed ID: 10629355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.
    Henderson VW; Paganini-Hill A; Emanuel CK; Dunn ME; Buckwalter JG
    Arch Neurol; 1994 Sep; 51(9):896-900. PubMed ID: 8080389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women.
    Manly JJ; Merchant CA; Jacobs DM; Small SA; Bell K; Ferin M; Mayeux R
    Neurology; 2000 Feb; 54(4):833-7. PubMed ID: 10690972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen and Alzheimer's disease: the story so far.
    Cholerton B; Gleason CE; Baker LD; Asthana S
    Drugs Aging; 2002; 19(6):405-27. PubMed ID: 12149049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensory Cueing of Autobiographical Memories in Normal Aging and Alzheimer's Disease: A Comparison Between Visual, Auditory, and Olfactory Information.
    Lopis D; Le Pape T; Manetta C; Conty L
    J Alzheimers Dis; 2021; 80(3):1169-1183. PubMed ID: 33646149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olfactory function in elderly people and patients with Alzheimer's disease.
    Hori Y; Matsuda O; Ichikawa S
    Psychogeriatrics; 2015 Sep; 15(3):179-85. PubMed ID: 25515307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons.
    Murphy C; Bacon AW; Bondi MW; Salmon DP
    Ann N Y Acad Sci; 1998 Nov; 855():744-50. PubMed ID: 9929680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olfactory functions in Parkinson's disease and Alzheimer's disease.
    Lehrner JP; Brücke T; Dal-Bianco P; Gatterer G; Kryspin-Exner I
    Chem Senses; 1997 Feb; 22(1):105-10. PubMed ID: 9056090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.
    Asthana S; Craft S; Baker LD; Raskind MA; Birnbaum RS; Lofgreen CP; Veith RC; Plymate SR
    Psychoneuroendocrinology; 1999 Aug; 24(6):657-77. PubMed ID: 10399774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Test-retest reliability and validity of the Sniffin' TOM odor memory test.
    Croy I; Zehner C; Larsson M; Zucco GM; Hummel T
    Chem Senses; 2015 Mar; 40(3):173-9. PubMed ID: 25550307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future therapeutic developments of estrogen use.
    Fillit H
    J Clin Pharmacol; 1995 Sep; 35(9S):25S-28S. PubMed ID: 8530715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women.
    van Amelsvoort T; Murphy DG; Robertson D; Daly E; Whitehead M; Abel K
    Psychoneuroendocrinology; 2003 Jan; 28(1):101-12. PubMed ID: 12445839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired visual and odor recognition memory span in patients with hippocampal lesions.
    Levy DA; Manns JR; Hopkins RO; Gold JJ; Broadbent NJ; Squire LR
    Learn Mem; 2003; 10(6):531-6. PubMed ID: 14657265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen replacement therapy: a perspective on cognitive impact.
    Tivis LJ; Nixon SJ; Green MD
    Assessment; 2001 Dec; 8(4):403-16. PubMed ID: 11785584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement therapy induces functional asymmetry on an odor memory/discrimination test.
    Doty RL; Kisat M; Tourbier I
    Brain Res; 2008 Jun; 1214():35-9. PubMed ID: 18466883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.